William Hagopian

Temporal development of the gut microbiome in early childhood from the TEDDY study

Christopher J. Stewart, Nadim J. Ajami, Jacqueline O’Brien et al. · Nature · 2018 · 1.9K citations · Full text

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

Kevan C. Herold, William Hagopian, Julie Auger et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text

The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

Tommi Vatanen, Eric A. Franzosa, Randall Schwager et al. · Nature · 2018 · 848 citations · Full text

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

Kevan C. Herold, Stephen E. Gitelman, Umesh Masharani et al. · Diabetes · 2005 · 631 citations · Full text

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Nicole Sherry, William Hagopian, Johnny Ludvigsson et al. · The Lancet · 2011 · 484 citations

Type 1, Disease Management, Diabetes Management +7